Evonik Industries AG (EVK) Fair Value & Analysis
Basic Materials · DE · Market cap €7.9B
Fair value as of: Jul 18, 2026
From 24 valuation models · updated 20 days ago
Fair value updated Jul 18, 2026, revised from €11.66 to €18.16 (+55.7%) since Jul 16, 2026. Share price +11.4% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from €13.55 (bear) to €18.81 (bull), base €18.16. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 60/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.
How to read this chart
60‑month range €11.87 – €22.17 · fair‑value band €13.55 – €18.81 · the €18.05 price screens below the €18.16 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 18, 2026.
Analysis
Evonik Industries AG (EVK) currently trades at €18.05, while our model-based Fair Value estimate is €18.16, implying the stock looks roughly 0.6% fairly valued today. We read business quality at 60/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Evonik Industries AG generated revenue of €13.7B at a net margin of 1.1%. Revenue declined 9.3% year over year. It earns a return on equity of 1.9%. Net debt stands at €3.4B. Fundamentals as of Jul 18, 2026
Our scenario range runs from €13.55 (bear case) to €18.81 (bull case); at €18.05, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 7% below its 52-week high and 45% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at 1%, EVK screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth DCF (€13.66) versus Earnings-Based (€4.73). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 72
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments.
Full company description
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and D-/L-methionine and lysine for animal nutrition. Its Custom Solutions segment provides additives for coatings, adhesives, sealants, polyurethane foams, and lubricants for the cosmetic, cleaning, and pharmaceutical industries. The Infrastructure segment engages in the infrastructure activities and offers butadiene, MTBE, butene-1, isononanol, and DINP for use in the plastic and packaging industries, production of rubber and fuels, and as plasticizers in the construction and automotive sectors. The company was founded in 1847 and is headquartered in Essen, Germany.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Evonik Industries AG reported revenue of €14.1B in FY2025 versus €15.0B in FY2021, a compound −1.5%/yr. Reported net income was €265M in FY2025, compounding −22.8%/yr from FY2021.
Watch EVK: get an alert when its fair value changes →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Global Precipitated Silica Market Forecast 2036: How Evonik Industries AG, Solvay SA & PPG Industries Inc. Are Driving Industry Growth A
- Evonik Industries AG (EVKIF) Q1 2026 Earnings Call Highlights: Surpassing Expectations Amidst ...
Peer Group
Specialty Chemicals · 680 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $520.74 | $226.27 | -57% |
| Nan Ya Plastics Corporation 1303 | 181.50 TWD | 255.83 TWD | +41% |
| Wanhua Chemical Group 600309 | ¥70.04 | ¥68.03 | -3% |
| Novozymes A/S NSISB | kr 428.20 | kr 179.66 | -58% |
| Asian Paints Limited ASIANPAINT | ₹2,689 | ₹668.81 | -75% |
| Solar Industries India Limited SOLARINDS | ₹18,236 | ₹2,793 | -85% |
| Pidilite Industries Limited PIDILITIND | ₹1,560 | ₹351.84 | -77% |
| PT Chandra Asri Pacific Tbk TPIA | 1,805 IDR | 2,888 IDR | +60% |
| Linde India Limited LINDEINDIA | ₹7,115 | ₹757.93 | -89% |
| Berger Paints India Limited BERGEPAINT | ₹493.70 | ₹164.29 | -67% |
Compare Evonik Industries AG with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Evonik Industries AG (EVK) overvalued or undervalued?
What is the fair value of EVK?
What is the quality score of EVK?
What is the revenue of Evonik Industries AG (EVK)?
What is the net profit margin of EVK?
Does Evonik Industries AG pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Evonik Industries AG and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.